|
Volumn 21, Issue 16, 2000, Pages 1293-1294
|
Heart failure and glucose abnormalities: An increasing combination with poor functional capacity and outcome
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLUCOSE;
INSULIN;
INSULIN DERIVATIVE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
DISORDERS OF CARBOHYDRATE METABOLISM;
EDITORIAL;
GLUCOSE BLOOD LEVEL;
HEART FAILURE;
HEART LEFT VENTRICLE FAILURE;
HEART VENTRICLE FUNCTION;
HUMAN;
HYPERINSULINEMIA;
INSULIN RESISTANCE;
PREVALENCE;
PRIORITY JOURNAL;
BLOOD GLUCOSE;
DIABETES MELLITUS;
HEART FAILURE, CONGESTIVE;
HUMANS;
INCIDENCE;
RISK FACTORS;
|
EID: 0033876769
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1053/euhj.2000.2198 Document Type: Editorial |
Times cited : (15)
|
References (12)
|